Regenerex Pharma (RGPX) Interest Expenses (2012 - 2025)

Regenerex Pharma (RGPX) has 10 years of Interest Expenses data on file, last reported at $4000.0 in Q3 2025.

• Interest Expenses for Q3 2025 came in at $4000.0, down 98.5% year-over-year; the trailing twelve-month figure through Sep 2025 was $358305.0 (down 7.39% YoY), and the FY2025 annual result was $320047.0, up 296.89% from the prior year.
• Interest Expenses slipped to $4000.0 in Q3 2025 per RGPX's latest filing, from $23596.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $303693.0 in Q1 2025 and troughed at $4000.0 in Q3 2025.
• A 5-year average of $53213.5 and a median of $19153.5 in 2023 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses surged 1244.16% in 2024, then sank 98.5% in 2025.
• A 5-year view of Interest Expenses shows it stood at $14548.0 in 2021, then advanced by 18.51% to $17241.0 in 2022, then climbed by 17.27% to $20219.0 in 2023, then soared by 33.62% to $27016.0 in 2024, then plunged by 85.19% to $4000.0 in 2025.
• Business Quant data shows RGPX's Interest Expenses at $4000.0 in Q3 2025, $23596.0 in Q2 2025, and $303693.0 in Q1 2025.